BNB$676.86-1.31%BRENT$95.05+5.04%BTC$77,711-1.93%COPPER$6.42-2.56%DJI$52,757-0.81%DOGE$0.0841-1.44%DXY99.68+0.26%ETH$2,396-1.99%GOLD$4,330-2.50%NDX$29,046-1.40%SILVER$64.16-3.54%SOL$91.24-2.07%SPX$7,626-0.78%US10Y4.80+0.80%VIX16.50+14.35%BNB$676.86-1.31%BRENT$95.05+5.04%BTC$77,711-1.93%COPPER$6.42-2.56%DJI$52,757-0.81%DOGE$0.0841-1.44%DXY99.68+0.26%ETH$2,396-1.99%GOLD$4,330-2.50%NDX$29,046-1.40%SILVER$64.16-3.54%SOL$91.24-2.07%SPX$7,626-0.78%US10Y4.80+0.80%VIX16.50+14.35%
MoneyMarket365.comReal-time markets + AI-ranked and AI-analyzed financial news
·Confidence 90%

Swiss Market Gains on Positive Novartis Drug Trial Results

Key takeaways

  • The Swiss market ended higher, supported by favorable results from Novartis' MS drug trials, despite ongoing geopolitical and economic concerns.
#Swiss Market#Novartis#Pharmaceuticals#Stock Market

Analysis

The Swiss market ended higher, supported by favorable results from Novartis' MS drug trials, despite ongoing geopolitical and economic concerns.

0 likes · 0 dislikes

Comments & Replies

with Google or GitHub to join the discussion.

  • No comments yet be the first to share your view.